WETS
NVCR icon

Wealth Enhancement Trust Services’s NovoCure NVCR Stock Holding History

Wealth Enhancement Trust Services’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.79K Buy
+118
New +$1.78K ﹤0.01% 1019

Other funds holding NVCR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Wealth Enhancement Trust Services's NVCR Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in NovoCure (NVCR) in Q2 2026: 118 shares worth $1.79K. The stake represents ﹤0.01% of the portfolio and ranks #1019 among its holdings.

133 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Wealth Enhancement Trust Services held 118 shares of NovoCure worth $1.79K as of Q2 2026.
  • NovoCure was a new Wealth Enhancement Trust Services position in Q2 2026.
  • NovoCure made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #1019 holding.
  • 133 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.